M., CalvoCastro, I., FernndezFernndez, C., DonapetryGarca, C., & PedrePieiro, A
The French drugmaker said the drug would not represent a meaningful improvement over existing treatments, including its own Dupixent Sanofi announced Friday it will not seek regulatory approval for amlitelimab in atopic dermatitis, ending development of the eczema drug as new chief executive Belen Garijo conducts a broad review of the company's pipeline
As Part of a Lifestyle GLP-1 boosters work best when integrated into a balanced routine: Supplements are not a substitute for a healthy lifestyle or medical treatment
Using substances and performance-enhancing drugs (PEDs) in sports is controversial
What I tell my patients is that BPC-157, if we use it, works best inside a plan: appropriate loading and rehab, real nutritional support, and sometimes alongside regenerative options like PRP injections for the joint or tendon itself
Side effects vary between individuals